普通外文研报
Invite: Corporate Access – Roadshow: Barclays Hosted: Moderna, Inc. (MRNA) - New York
研报英文原文证据摘录
Invite: Corporate Access – Roadshow: Barclays Hosted: Moderna, Inc. (MRNA) - New York
Eliana Merle, CFA, joined Barclays in November 2025 as
an Equity Research Analyst to cover U.S. Small & Mid Cap
Biotechnology. She has over a decade of sell-side equity
research experience in the sector; most recently, Ellie
worked as a Senior Equity Research Analyst at UBS in
Biotechnology for five years. Prior to that, she also
covered Small & Mid Cap Biotechnology at Cantor
Fitzgerald and held positions at Credit Suisse and
Deutsche Bank in Biotechnology Equity Research. Ellie
graduated from Pomona College with a degree in
Economics.
View Analyst Page
U.S. Small & Mid Cap Biotechnology
Eliana Merle, CFA
+1 212 526 9445
BCI, US
This event is intended for Barclays institutional investor clients only. This event is strictly and solely
for the benefit of the intended recipients. Please do not forward this invitation to any other party
without written consent from Barclays Research. Barclays' Investment Bankers are prohibited from
attending this event. Participant comments are not for attribution.
If your firm is in-scope for research unbundling under MiFID II and you require further information
regarding pricing to participate in this Barclays Research content event, please contact your sales
representative.
Barclays Events Terms of Service | Barclays Events Privacy Notice
Disclaimer:
BARCLAYS
This communication has been prepared by Barclays.
“Barclays” means any entity within the Barclays Group of companies, where “Barclays Group” means
Barclays Bank PLC, Barclays PLC and any of their subsidiaries, affiliates, ultimate holding company
and any subsidiaries or affiliates of such holding company.
CONFLICTS OF INTEREST
BARCLAYS IS A FULL SERVICE INVESTMENT BANK.
本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。
打开研报阅读器